These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10590328)

  • 1. Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines.
    Czeschinski PA; Binding N; Witting U
    Vaccine; 2000 Jan; 18(11-12):1074-80. PubMed ID: 10590328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous vaccination against hepatitis A and B: results of a controlled study.
    Ambrosch F; André FE; Delem A; D'Hondt E; Jonas S; Kunz C; Safary A; Wiedermann G
    Vaccine; 1992; 10 Suppl 1():S142-5. PubMed ID: 1335647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine.
    Ambrosch F; Wiedermann G; André FE; Delem A; Gregor H; Hofmann H; D'Hondt E; Kundi M; Wynen J; Kunz C
    J Med Virol; 1994 Dec; 44(4):452-6. PubMed ID: 7897380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and reactogenicity of a combined hepatitis A-hepatitis B vaccine in adolescents.
    Thompson SC; Norris M
    Int J Infect Dis; 1998; 2(4):193-6. PubMed ID: 9763500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous vaccination for hepatitis A and B.
    Flehmig B; Heinricy U; Pfisterer M
    J Infect Dis; 1990 May; 161(5):865-8. PubMed ID: 2157770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?
    Kallinowski B; Knöll A; Lindner E; Sänger R; Stremmel W; Vollmar J; Zieger B; Jilg W
    Vaccine; 2000 Aug; 19(1):16-22. PubMed ID: 10924782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
    Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
    Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.
    Knöll A; Hottenträger B; Kainz J; Bretschneider B; Jilg W
    Vaccine; 2000 Apr; 18(19):2029-32. PubMed ID: 10706965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in healthy Chilean subjects.
    Prado V; Riedemann S; Ibarra H; Potin M
    Int J Infect Dis; 2002 Jun; 6(2):129-33. PubMed ID: 12121601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response after hepatitis A vaccination in haemodialysis patients: comparison with hepatitis B vaccination.
    Kuramoto I; Fujiyama S; Matsushita K; Sato T
    J Gastroenterol Hepatol; 1994; 9(3):228-31. PubMed ID: 8054520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.
    Burgess MA; Rodger AJ; Waite SA; Collard F
    Vaccine; 2001 Sep; 19(32):4835-41. PubMed ID: 11535336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix in healthy Indian children.
    Guptan RC; Thakur V; Safary A; Sarin SK
    Vaccine; 2002 May; 20(16):2102-6. PubMed ID: 11972979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
    Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO
    J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.